Literature DB >> 12528872

Multiple myeloma: how far have we come?

Kenneth C Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12528872     DOI： 10.4065/78.1.15

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  9 in total

1.  Functional results of vertebral augmentation techniques in pathological vertebral fractures of myelomatous patients.

Authors:  Kamil Cagri Köse; Oguz Cebesoy; Burak Akan; Levent Altinel; Derya Dinçer; Tarik Yazar
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

2.  Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results.

Authors:  Michael Fenchel; Marina Konaktchieva; Katja Weisel; Sabina Kraus; Harald Brodoefel; Claus D Claussen; Marius Horger
Journal:  Eur Radiol       Date:  2010-07-01       Impact factor: 5.315

3.  Genetic Analysis of Acid β-Glucosidase in Patients with Multiple Myeloma from Central Taiwan: A Small-Cohort Case-Control Study.

Authors:  Wei-De Lin; Fuu-Jen Tsai
Journal:  Biomed Hub       Date:  2021-11-29

4.  Human-like mouse models for testing the efficacy and safety of anti-beta2-microglobulin monoclonal antibodies to treat myeloma.

Authors:  Jing Yang; Yabing Cao; Sungyongl Hong; Haiyan Li; Jianfei Qian; Larry W Kwak; Qing Yi
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

5.  Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells.

Authors:  Nassera Aouali; Angeliki Broukou; Manon Bosseler; Olivier Keunen; Vincent Schlesser; Bassam Janji; Valerie Palissot; Philippe Stordeur; Guy Berchem
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

6.  Downregulation of Sprouty homolog 2 by microRNA-21 inhibits proliferation, metastasis and invasion, however promotes the apoptosis of multiple myeloma cells.

Authors:  Jin-Hang Wang; Wen-Wen Zhou; Shi-Tong Cheng; Bo-Xin Liu; Fu-Rong Liu; Jian-Qing Song
Journal:  Mol Med Rep       Date:  2015-03-30       Impact factor: 2.952

7.  Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells.

Authors:  Shaoling Wu; Xindong Zhao; Zhongguang Cui; Chunting Zhao; Yuzhen Wang; Li Du; Yanhui Li
Journal:  Int J Nanomedicine       Date:  2014-03-14

8.  Analysis of a Compartmental Model of Endogenous Immunoglobulin G Metabolism with Application to Multiple Myeloma.

Authors:  Felicity Kendrick; Neil D Evans; Bertrand Arnulf; Hervé Avet-Loiseau; Olivier Decaux; Thomas Dejoie; Guillemette Fouquet; Stéphanie Guidez; Stéphanie Harel; Benjamin Hebraud; Vincent Javaugue; Valentine Richez; Susanna Schraen; Cyrille Touzeau; Philippe Moreau; Xavier Leleu; Stephen Harding; Michael J Chappell
Journal:  Front Physiol       Date:  2017-03-17       Impact factor: 4.566

9.  The Safety Profile of Concurrent Therapy for Multiple Myeloma in the Modern Era.

Authors:  Lucas Resende Salgado; Shutao Wang; Ava Adler; Sanders Chang; Meng Ru; Erin Moshier; Kavita Dharmarajan; Hearn Jay Cho; Richard Bakst
Journal:  Adv Radiat Oncol       Date:  2018-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.